MAPS Public Benefit Corporation (MAPS PBC)
Edit

MAPS Public Benefit Corporation (MAPS PBC)

https://mapspublicbenefit.com/
Last activity: 06.03.2023
Active
Categories: DevelopmentDrugFoodTechHealthTechMapsMedtechPublicResearchSalesTraining
MAPS Public Benefit Corporation (MAPS PBC) catalyzes healing and well-being through psychedelic drug development, therapist training programs, and sales of prescription psychedelics. We are currently focused on developing MDMA-assisted therapy as a breakthrough therapy for posttraumatic stress disorder (PTSD), with plans to submit for U.S. Food and Drug Administration (FDA) approval in 2023. The results of our successful, pivotal Phase 3 clinical trial were recently published in Nature Medicine and profiled on the front page of The New York Times.

Founded in 2014 as a public benefit corporation, MAPS PBC prioritizes public benefit over profit. We are a wholly owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS), a 501(c)(3) non-profit organization that has been working for over three decades to develop medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana.

MAPS PBC is a distributed team that uses technology and periodic in-person gatherings to stay connected. We seek candidates who are comfortable with and skilled at remote work and collaboration.
Followers
12.34K
Website visits
23.9K /mo.
Mentions
4
Location: United States, California, Santa Cruz
Employees: 51-200
Founded date: 2014

Investors 1

DateNameWebsite
-Empath Ven...empath.vc

Mentions in press and media 4

DateTitleDescription
06.03.2023Here's what MDMA does to your brain and bodyRedeem now MDMA has been around for over a hundred years. Today, it's best known as a party drug because it can cause feelings of empathy and sociability, but it's also being studied as a possible treatment for a host of different illnesses...
29.12.2021It’s Been A Banner Year For MAPS Public Benefit Corporation And The Women Leading ItThe results of MAPS PBC's latest Phase 3 trial revealed that after receiving a combination of talk ... [+] therapy and MDMA, 67 percent of participants who received the drug no longer met the diagnostic criteria for PTSD, compared to 32 per...
-A psychedelic therapist allegedly took millions from a Holocaust survivor, highlighting worries about elders taking hallucinogensHe made a new life for himself in California. After surviving the Holocaust and growing up under Hungarian fascism and Russia’s communist regime, George Sarlo arrived in the United States as an 18-year-old refugee. Over the decades, he beca...
-Lykos Therapeutics“Home - Lykos”

Reviews 0

Sign up to leave a review

Sign up Log In